Literature DB >> 9578241

Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance).

H Globerman1, E Karnieli.   

Abstract

OBJECTIVE: To test the hypothesis that the triad of hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN syndrome) in the presence of obesity, also known as type C insulin resistance (type C), is caused by mutations at the tyrosine kinase domain of the insulin receptor gene.
DESIGN: A candidate gene approach to study the molecular basis for a syndrome of obesity.
SUBJECTS: 15 patients with type C insulin resistance and 25 control individuals. MEASUREMENTS: Analysis of polymerase chain reaction (PCR) products of exons 17 to 21 of the insulin receptor gene, comprising the tyrosine kinase domain, for single strand conformational polymorphisms (SSCP) and sequence analysis of exons with variant SSCP patterns.
RESULTS: A synonymous C to T substitution in position 3 of codon 984, which does not alter the amino acid predicted, was found in one patient and in four of 25 control individuals.
CONCLUSION: Type C insulin resistance is not commonly caused by mutations in the tyrosine kinase domain of the insulin receptor gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9578241     DOI: 10.1038/sj.ijo.0800593

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  3 in total

1.  Paradigm shift in the management of type B insulin resistance.

Authors:  Jun Hwa Hong; Hyun Jin Kim; Kang Seo Park; Bon Jeong Ku
Journal:  Ann Transl Med       Date:  2018-12

Review 2.  Functional genomics of PCOS: from GWAS to molecular mechanisms.

Authors:  Jan M McAllister; Richard S Legro; Bhavi P Modi; Jerome F Strauss
Journal:  Trends Endocrinol Metab       Date:  2015-01-15       Impact factor: 12.015

3.  Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study.

Authors:  Yusuke Hirota; Hirotsugu Suwanai; Toshimasa Yamauchi; Takashi Kadowaki
Journal:  J Diabetes Res       Date:  2020-04-04       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.